Principal Investigator
Carl Landgren
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250076
Clinical Trial Summary
Elranatamab, Lenalidomide, Dexamethasone in Newly Diagnosed Multiple Myeloma, a Clinical and Correlative Phase 2 Study
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Myeloma
Contact Information
Phone Number
305-243-2647